CFLT vs IMDX · rev $963.6M vs rev $271.0K
Confluent Inc (CFLT) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
CFLT currently screens at market cap $11.13B. IMDX currently screens at market cap $0.
Not investment advice. Open the CFLT and IMDX stock pages for the full models.
Not investment advice.